Literature DB >> 15928877

Current approaches to the diagnosis and management of hepatocellular carcinoma.

J F Perry1, H Poustchi, J George, G C Farrell, G W McCaughan, S I Strasser.   

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, and incidence rates in Western countries are on the rise. Despite many options, no ideal treatment yet exists for this highly malignant tumour, and management strategies have varied accordingly. This review summarises current strategies for the diagnosis and management of HCC.

Entities:  

Mesh：

Year:  2005        PMID： 15928877     DOI： 10.1007/s10238-005-0058-3

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN： 1591-8890            Impact factor:   3.984


  3 in total

1.  MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma.

Authors:  Lijun Wu; Ping Chen; Jun Ying; Qi Zhang; Fuchen Liu; Bin Lv; Zhihui Che; Wenli Zhang; Mengmeng Wu; Jun Zhang; Dongqin Yang; Jie Liu
Journal:  Clin Exp Med       Date:  2019-09-06       Impact factor: 3.984

2.  An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma.

Authors:  J Huang; J Yang; Y Lei; H Gao; T Wei; L Luo; F Zhang; H Chen; Q Zeng; L Guo
Journal:  Oncogenesis       Date:  2016-05-30       Impact factor: 7.485

3.  Significance of PRO2000/ANCCA expression, a novel proliferation-associated protein in hepatocellular carcinoma.

Authors:  Jie Yang; Jie Huang; Luqiao Luo; Zhenzhu Chen; Ying Guo; Linlang Guo
Journal:  Cancer Cell Int       Date:  2014-04-04       Impact factor: 5.722
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.